This work uncovers the importance of SUMOylation in the epigenetic control of the 4q35 locus and DUX4 transcription, providing a potential therapeutic strategy to modulate DUX4 expression in FSHD. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.